These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2872503)

  • 21. Glutamate neurotoxicity and Huntington's chorea.
    Olney JW; de Gubareff T
    Nature; 1978 Feb; 271(5645):557-9. PubMed ID: 146165
    [No Abstract]   [Full Text] [Related]  

  • 22. Adult onset myoclonic Huntington's disease.
    Carella F; Scaioli V; Ciano C; Binelli S; Oliva D; Girotti F
    Mov Disord; 1993 Apr; 8(2):201-5. PubMed ID: 8474490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration.
    Amin EM; Reza BA; Morteza BR; Maryam MM; Ali M; Zeinab N
    Neurol Res; 2008 Dec; 30(10):1086-90. PubMed ID: 18768110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
    Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease.
    Albin RL; Young AB; Penney JB; Handelin B; Balfour R; Anderson KD; Markel DS; Tourtellotte WW; Reiner A
    N Engl J Med; 1990 May; 322(18):1293-8. PubMed ID: 1691447
    [No Abstract]   [Full Text] [Related]  

  • 26. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients].
    Botsch H; Oepen G; Deuschl G; Wolff G
    Rofo; 1987 Dec; 147(6):666-8. PubMed ID: 2827263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.
    de la Monte SM; Vonsattel JP; Richardson EP
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):516-25. PubMed ID: 2971785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease.
    Aylward EH
    Brain Res Bull; 2007 Apr; 72(2-3):152-8. PubMed ID: 17352939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic options for Huntington's disease.
    Grimbergen YA; Roos RA
    Curr Opin Investig Drugs; 2003 Jan; 4(1):51-4. PubMed ID: 12625029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea.
    Sramka M; Rattaj M; Molina H; Vojtassák J; Belan V; Ruzický E
    Stereotact Funct Neurosurg; 1992; 58(1-4):79-83. PubMed ID: 1439353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Huntington's chorea: selective depletion of activity of angiotensin coverting enzyme in the corpus striatum.
    Arregui A; Bennett JP; Bird ED; Yamamura HI; Iversen LL; Snyder SH
    Ann Neurol; 1977 Oct; 2(4):294-8. PubMed ID: 214022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum).
    Subramaniam S; Snyder SH
    Neuropharmacology; 2011 Jun; 60(7-8):1187-92. PubMed ID: 21044641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of immunolabelling in the determination of Huntington's disease neuropathy.
    Ashton JC
    Brain; 2011 Nov; 134(Pt 11):e191; author reply e192. PubMed ID: 21555335
    [No Abstract]   [Full Text] [Related]  

  • 34. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the striatum in processing language rules: evidence from word perception in Huntington's disease.
    Teichmann M; Dupoux E; Kouider S; Bachoud-Lévi AC
    J Cogn Neurosci; 2006 Sep; 18(9):1555-69. PubMed ID: 16989555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations on the use of methysergide in Huntington's chorea.
    Klawans HL; Rubovits R; Ringel SP; Weiner WJ
    Neurology; 1972 Sep; 22(9):929-33. PubMed ID: 4343347
    [No Abstract]   [Full Text] [Related]  

  • 37. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease.
    Francelle L; Galvan L; Gaillard MC; Guillermier M; Houitte D; Bonvento G; Petit F; Jan C; Dufour N; Hantraye P; Elalouf JM; De Chaldée M; Déglon N; Brouillet E
    Hum Mol Genet; 2015 Mar; 24(6):1563-73. PubMed ID: 25398949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic tests for choreoacanthocytosis.
    Feinberg TE; Cianci CD; Morrow JS; Pehta JC; Redman CM; Huima T; Koroshetz WJ
    Neurology; 1991 Jul; 41(7):1000-6. PubMed ID: 1829792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular insights into cortico-striatal miscommunications in Huntington's disease.
    Veldman MB; Yang XW
    Curr Opin Neurobiol; 2018 Feb; 48():79-89. PubMed ID: 29125980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.
    Reuter I; Hu MT; Andrews TC; Brooks DJ; Clough C; Chaudhuri KR
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):238-41. PubMed ID: 10644798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.